State of Texas prescribed anti-psychotic drug to youth offenders while challenging its effectiveness in court
Left hand, we’d like to introduce you to the right.
For two years while the state of Texas was suing Johnson & Johnson for fraudulently inflating the cost and effectiveness of the anti-psychotic drug Risperdal, taxpayers picked up a $247,666.87 bill for the Texas Youth Commission to continue prescribing the drug to young inmates.
Johnson & Johnson and a subsidiary, Janssen Pharmaceuticals Inc., agreed in January to pay the state $158 million to settle the lawsuit. The state had been seeking $579 million.